Thomas' IOM Plan Receiving Generally Positive Response
So far, many of the directors of the $3 billion California stem cell agency today seem to be endorsing the plan proposed by Chairman J.T. Thomas to meet the sweeping recommendations by the Institute of Medicine.
Several members stressed the need to remove the perception of conflicts of interest on the board, as identified by Institute of Medicine and o…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.